Atrial Fibrillation Archives - Medical Conferences

Home > Disease Areas > Atrial Fibrillation

ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration

Presented By

Dr William McIntyre, Population Health Research Institute, Canada

Trial

ARTESiA

Conference

EHRA 2024

Type

News article

29 April 2024 15:33

Abelacimab substantially lowers bleeding risk compared with rivaroxaban

Presented By

Dr Christian Ruff, Brigham and Women’s Hospital, USA

Trial

Phase 2, AZALEA-TIMI 71

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:22

CEASE-AF meets primary endpoint in persistent AF

Presented By

Prof. Nicolas Doll, Georg-August University, Germany

Trial

CEASE-AF

Conference

EHRA 2023

Type

News article

3 May 2023 16:16

Online First

OPTION: LAAC over OAC after ablation in patients with AF and increased stroke risk

Presented By

Prof. Oussama Wazni, Cleveland Clinic, USA

Trial

OPTION

Conference

AHA 2024

Type

News article

20 November 2024 15:53

Head-to-head: Cryoballoon vs radiofrequency ablation in persistent AF

Presented By

Dr Kengo Kusano, National Cerebral and Cardiovascular Center, Japan

Trial

CRRF-PeAF

Conference

AHA 2024

Type

News article

19 November 2024 16:34

ARREST-AF: The true impact of risk factor management on AF recurrence after ablation

Presented By

Prof. Rajeev Pathak, University of Adelaide, Australia

Trial

ARREST-AF

Conference

AHA 2024

Type

News article

19 November 2024 16:29

Medical Conferences

Atrial Fibrillation

Featured articles

ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration

Abelacimab substantially lowers bleeding risk compared with rivaroxaban

CEASE-AF meets primary endpoint in persistent AF

CONTENTS

Online First

OPTION: LAAC over OAC after ablation in patients with AF and increased stroke risk

Head-to-head: Cryoballoon vs radiofrequency ablation in persistent AF

ARREST-AF: The true impact of risk factor management on AF recurrence after ablation